Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. PRME
8. AWK
9. DRI
10. USO

Go back to Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA
Eisai Co Ltd (AMEX: ESALF) Delayed: 31.55 --0 (-0%)
Previous Close $31.55    52 Week High $66.25 
Open $31.55    52 Week Low $53.50 
Day High $31.55    P/E N/A 
Day Low $31.55    EPS $0.00 
Volume 24       

Eisai Co Ltd American Depositary Shares (AMEX: ESALY) Delayed: 61.51 --0 (-0%)
Previous Close $61.51    52 Week High $67.60 
Open $49.73    52 Week Low $53.55 
Day High $61.51    P/E N/A 
Day Low $61.51    EPS $0.00 
Volume 1,907,007       

Merck & Co. (NYSE: MRK) Delayed: 148.78 --0 (-0%)
Previous Close $148.78    52 Week High $65.46 
Open $148.78    52 Week Low $47.97 
Day High $148.78    P/E 101.21 
Day Low $148.78    EPS $1.47 
Volume 2,565